Calcimimetics in the treatment of primary hyperparathyroidism.
Antoniucci
Diana M
DM
Department of Veterans Affairs Medical Center, Department of Medicine, University of California, San Francisco 94121, USA.
Shoback
Dolores
D
D000814:Aniline Compounds / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D002118:Calcium / Q000819:agonists* / Q000378:metabolism; D002986:Clinical Trials as Topic; D006801:Humans; D006961:Hyperparathyroidism / Q000188:drug therapy* / Q000378:metabolism; D018716:Molecular Mimicry; D010627:Phenethylamines; D011437:Propylamines; D044169:Receptors, Calcium-Sensing; D011956:Receptors, Cell Surface / Q000187:drug effects / Q000378:metabolism
D000814:Aniline Compounds; C107873:N-(2-chlorophenylpropyl)-1-(3-methoxyphenyl)ethylamine; D010627:Phenethylamines; D011437:Propylamines; D044169:Receptors, Calcium-Sensing; D011956:Receptors, Cell Surface; D002118:Calcium